Ethiopia Antimalarial in Vivo Efficacy Study 2012

PHASE4CompletedINTERVENTIONAL
Enrollment

398

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Plasmodium Vivax Infection
Interventions
DRUG

Artemether-lumefantrine combination

DRUG

Primaquine

DRUG

Chloroquine

Trial Locations (2)

Unknown

Bishoftu Malaria Center, Bishoftu

Batu Health Center, Zeway

All Listed Sponsors
collaborator

Ethiopian Health and Nutrition Research Institute

OTHER

collaborator

Federal Minstry of Health of Ethiopia

OTHER_GOV

collaborator

Columbia University

OTHER

collaborator

Oromia Regional Health Bureau, Ethiopia

UNKNOWN

collaborator

United States Agency for International Development (USAID)

FED

collaborator

Menzies School of Health Research

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT01680406 - Ethiopia Antimalarial in Vivo Efficacy Study 2012 | Biotech Hunter | Biotech Hunter